pillbase.ru

Thalidomide BMS (previously Thalidomide Celgene)

Active substance: thalidomide

thalidomide

Centralised EU authorisationActive

Marketing holder: Bristol-Myers Squibb Pharma EEIG

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 4
  • Thalomid
    CAPSULE · THALIDOMIDE 100 mg/1
    59572-210
    Celgene Corporation
  • Thalomid
    CAPSULE · THALIDOMIDE 200 mg/1
    59572-220
    Celgene Corporation
  • Thalomid
    CAPSULE · THALIDOMIDE 150 mg/1
    59572-215
    Celgene Corporation
  • Thalomid
    CAPSULE · THALIDOMIDE 50 mg/1
    59572-205
    Celgene Corporation
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a12091-f8b7-7580-a0c3-286791867693,01a12098-df5d-7f5d-b0a3-0bb2290321a8,01a1209b-57ed-742a-9529-eb79ef2047e2,01a1209d-a13c-77d4-8e5e-ffb707dcb9b2;count=4 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/000823
Registration status
Active
ATC code
L04AX02
Sources
  • product · EMA · EMEA/H/C/000823 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/000823 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/000823 · Verified 2026-10-09